Laurus Labs latest update leaves the fair value estimate at roughly ₹821.93 per share with a steady discount rate of 12.76%, underscoring that the market narrative is shifting more on expectations ...

Revenue: INR1,570 crores, reflecting a 31% year-on-year growth. Gross Margin: 59%, an increase of more than 4% due to better product mix and process improvements. EBITDA: INR389 crores with a margin ...

An analyst from Master Capital Services said that Bank of India has taken strong support at its long-term horizontal support ...

Last night, after midnight, I read the last lines of Laurus, a newly translated Russian novel by Eugene Vodolazkin, and thought it surely must be the most perfect ending ever. There is no way it could ...

Compared to the previous quarter, the revenue grew by 20.48% and the profit increased by 226.75%. The Selling, general & administrative expenses rose by 3.97% q-o-q & increased by 19.99% Y-o-Y. The ...

Hyderabad: Laurus Bio, a subsidiary of Hyderabad-based biopharma player Laurus Labs Ltd, has secured an equity investment of Rs 120 crore from Eight Roads Ventures and F-Prime Capital. Laurus Labs ...

Laurus Labs API segment is also well set to clock strong growth backed by the company’s increasing focus to diversify into new therapy areas - anti-diabetes and cardiology along with an eye to gain a ...